Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Gross Profit: 2018-2025

Historic Gross Profit for Sunshine Biopharma (SBFM) over the last 7 years, with Sep 2025 value amounting to $3.1 million.

  • Sunshine Biopharma's Gross Profit rose 7.24% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year increase of 21.44%. This contributed to the annual value of $10.7 million for FY2024, which is 27.95% up from last year.
  • Per Sunshine Biopharma's latest filing, its Gross Profit stood at $3.1 million for Q3 2025, which was down 10.21% from $3.4 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Gross Profit registered a high of $3.4 million during Q2 2025, and its lowest value of $21,538 during Q1 2021.
  • Moreover, its 3-year median value for Gross Profit was $2.6 million (2023), whereas its average is $2.6 million.
  • Data for Sunshine Biopharma's Gross Profit shows a peak YoY spiked of 6,157.61% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Sunshine Biopharma's Gross Profit stood at $23,829 in 2021, then surged by 6,157.61% to $1.5 million in 2022, then skyrocketed by 72.22% to $2.6 million in 2023, then grew by 20.44% to $3.1 million in 2024, then grew by 7.24% to $3.1 million in 2025.
  • Its Gross Profit was $3.1 million in Q3 2025, compared to $3.4 million in Q2 2025 and $2.7 million in Q1 2025.